Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13427 | 774 | 34.8 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1696 | 6158 | HEPATITIS E VIRUS//HEPATITIS A//HEPATITIS E |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FUNDACIO RECERCA MUTUA TERRASSA | Address | 4 | 75% | 0% | 3 |
2 | INCUMBENT LAURA WARZ KIP CHAIR AUTOIMMUNE | Address | 3 | 24% | 1% | 11 |
3 | AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS | Author keyword | 3 | 50% | 1% | 4 |
4 | ASIA SYNDROME | Author keyword | 3 | 42% | 1% | 5 |
5 | ZABLUDOWICZ AUTOIMMUNE DIS | Address | 2 | 11% | 3% | 20 |
6 | POST VACCINATION | Author keyword | 2 | 40% | 1% | 4 |
7 | AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANTS ASIA | Author keyword | 2 | 43% | 0% | 3 |
8 | DIREZ GEN SANITA MIL | Address | 1 | 31% | 1% | 4 |
9 | AUTOIMMUNITY DISEASES | Author keyword | 1 | 100% | 0% | 2 |
10 | CHEO IBD | Address | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INFLUENZA VIRUS VACCINATION | 15 | 82% | 1% | 9 |
2 | HEPATITIS B VACCINATION | 12 | 15% | 9% | 72 |
3 | TNF BLOCKERS | 6 | 100% | 1% | 4 |
4 | DISSEMINATED PRIMARY VARICELLA | 4 | 67% | 1% | 4 |
5 | NERVOUS SYSTEM DEMYELINATION | 4 | 26% | 2% | 14 |
6 | ADJUVANTS ASIA | 3 | 50% | 1% | 4 |
7 | BATTAFARANO ET AL | 2 | 67% | 0% | 2 |
8 | CHURG STRAUSS VASCULITIS | 2 | 67% | 0% | 2 |
9 | SWINE INFLUENZA VACCINATION | 2 | 67% | 0% | 2 |
10 | INFLUENZA IMMUNIZATION | 2 | 14% | 2% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Predicting post-vaccination autoimmunity: Who might be at risk? | 2015 | 3 | 40 | 40% |
A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient | 2010 | 60 | 36 | 75% |
Vaccination of patients with autoimmune inflammatory rheumatic diseases | 2015 | 1 | 119 | 65% |
'ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants | 2011 | 158 | 42 | 19% |
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases | 2011 | 41 | 96 | 57% |
Vaccinating the inflammatory bowel disease patient | 2015 | 1 | 64 | 48% |
Vaccinations in patients with immune-mediated inflammatory diseases | 2010 | 66 | 87 | 43% |
Revisiting adverse reactions to vaccines: A critical appraisal of Autoimmune Syndrome Induced by Adjuvants (ASIA) | 2015 | 1 | 39 | 46% |
Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review | 2012 | 20 | 20 | 65% |
On the relationship between human papilloma virus vaccine and autoimmune diseases | 2014 | 12 | 37 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FUNDACIO RECERCA MUTUA TERRASSA | 4 | 75% | 0.4% | 3 |
2 | INCUMBENT LAURA WARZ KIP CHAIR AUTOIMMUNE | 3 | 24% | 1.4% | 11 |
3 | ZABLUDOWICZ AUTOIMMUNE DIS | 2 | 11% | 2.6% | 20 |
4 | DIREZ GEN SANITA MIL | 1 | 31% | 0.5% | 4 |
5 | CHEO IBD | 1 | 50% | 0.3% | 2 |
6 | IND PREVENT MED | 1 | 100% | 0.3% | 2 |
7 | PHARMACOEPIDEMIOL INFECT DIS UNIT PHEMI | 1 | 100% | 0.3% | 2 |
8 | REFERRAL ADULT IMMUNE CYTOPENIAS | 1 | 100% | 0.3% | 2 |
9 | RUTH BRUCE R ORT MED | 1 | 100% | 0.3% | 2 |
10 | ALLERGOL RHEUMATOL CLIN IMMUNOL | 1 | 17% | 0.8% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000194666 | CRA DIP//SECC INMUNOGENET//SERV ATENDIMENTO ESPECIALIZADO SMS BELFORD ROXO |
2 | 0.0000161050 | POSTVIRAL ENCEPHALITIS//RELAPSING HEPATITIS//RHEUMATOL METAB BONE JOINT DIS |
3 | 0.0000111717 | DAS181//PARAINFLUENZA//ALBERTA TRANSPLANT SCI |
4 | 0.0000111566 | HBV REACTIVATION//HEPATITIS B VIRUS REACTIVATION//HEPATITIS B REACTIVATION |
5 | 0.0000083241 | GELATIN ALLERGY//VACCINE ALLERGY//ITCHING NODULE |
6 | 0.0000073749 | ALUMINUM HYDROXIDE ADJUVANT//ANTIGEN ADSORPTION//MACROPHAGIC MYOFASCIITIS |
7 | 0.0000062891 | SLAM ASSOCIATED PROTEIN SAP//ANTI CMV ANTIBODIES//VARICELLA ARTHRITIS |
8 | 0.0000060898 | PRISTANE//PAR GENE//PRISTANE INDUCED LUPUS |
9 | 0.0000057029 | INFLIXIMAB//VEDOLIZUMAB//ADALIMUMAB |
10 | 0.0000056658 | ACUTE DISSEMINATED ENCEPHALOMYELITIS//ADEM//BALOS CONCENTRIC SCLEROSIS |